| Financial Year |
March 31 2023 |
| Monetary Funds |
53,124,419.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,758,714.54 |
| Accounts Receivable |
392,020,637.59 |
| Advances to Suppliers |
29,996,917.22 |
| Other Receivables |
12,999,671.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
376,988,365.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,646,068.80 |
| Total Current Assets |
911,534,794.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,688,740.97 |
| Investment Properties |
-- |
| Fixed Assetes |
784,100,853.07 |
| Under-construction Projects |
119,330,505.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,739,093.95 |
| R&D expenses |
-- |
| Goodwill |
593,463,979.30 |
| Long-Term Deferred and Prepaid Expenses |
36,998,877.65 |
| Deferred Income Tax Assets |
53,025,585.97 |
| Other Non-Current Assets |
9,839,095.75 |
| Sub-Total of Non-Current Assets |
2,009,920,753.96 |
| Total Assets |
2,921,455,548.65 |
| Short-Term Loans |
1,332,253,973.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
228,703,319.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,778,702.95 |
| Taxes Payable |
71,092,050.76 |
| Interest Payable |
27,647,479.35 |
| Dividend Payable |
720,000.00 |
| Other payables |
1,076,186,636.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
315,710,864.74 |
| Other Current Liabilities |
7,579,575.48 |
| Sub-Total of Current Liabilities |
3,095,690,310.60 |
| Long-term Loans |
62,565,957.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
66,907,777.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,054,134.81 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
7,389,775.20 |
| Sub-Total of Non-Current Liabilities |
326,290,907.06 |
| Total Liabilities |
3,421,981,217.66 |
| Paid-In Capital(Or Share Stock) |
671,616,059.00 |
| Capital Surplus |
2,031,246,631.38 |
| Surplus Reserve |
46,988,336.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,139,426,462.94 |
| Minority Stockholder's Interest |
-10,114,930.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-490,410,738.74 |
| Owner's Equity（Stockholder's Equity） |
-500,525,669.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,921,455,548.65 |
